Dr. Bruce Cheson from Georgetown University discusses the practical applications of personalized therapy in chronic lymphocytic leukemia (CLL): what is possible today and what is not.
- Personalized therapies are evolving and have important implications in predicting response to treatment
- The classification of leukemia and lymphoma is becoming more specific, as are the therapies.
- Classification of CLL is likewise become more “personalized”.
In this short audio interview from the LFR’s North American Educational Forum on Lymphoma that was held in Brooklyn Oct. 2-4, 2015, Dr. Cheson outlines the evolution of our understanding of blood cancers generally, and CLL specifically, during his medical career.
Please enjoy listening to it here.
Brian Koffman, MD 1/18/16